TerrAscend Subsidiary Obtains Medical Marijuana Processor License

TerrAscend Corp. TERTRSSF announced Thursday that its subsidiary TerrAscend Utah, LLC obtained approval for a medical cannabis processor license by the Utah Department of Agriculture and Food. TerrAscend Utah's processing facility will be based in St George, Utah.

"We are pleased St. George will have a company like TerrAscend in our community," Jeriah Threlfall, President, St George Economic Development said in a statement. "TerrAscend has a proven record of pharmaceutical research and development of products that meet the high standards our state policymakers intended when they passed the law."

Benzinga's Cannabis Capital Conference returns to Miami Feb. 24-25 with North America's largest B2B cannabis gathering, bringing together capital, cannabis executives, thought leaders and more!

Jason Ackerman, TerrAscend's Executive Chairman also commented on the milestone.

"We are thrilled to have been chosen by the Utah Department of Agriculture and Food for a Medical Cannabis Processor License," Ackerman said. "We look forward to becoming an integral part of the St. George community and serving the patients of Utah. We will begin the process of transferring TerrAscend's cannabis processing and product manufacturing know-how, as well as our house of brands, to meet patients' needs as soon as possible."

TerrAscend is considered to be the first and only cannabis company with a license for sale in the U.S., Canada and Europe.

The company’s shares traded at $2.40 per share on Thursday morning.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsmedical marijuanaUtah
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.